These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 36265456)

  • 1. Isolation and in vitro Expansion of Regulatory T Cells from β-Thalassemia Major Kids and in vitro Evaluation of Their Plasticity and Inhibitory Effects in the Presence of Pro-Inflammatory Cytokines.
    Mansourabadi AH; Mohamed Khosroshahi L; Noorbakhsh F; Hamidieh AA; Amirzargar A
    Int Arch Allergy Immunol; 2023; 184(1):63-75. PubMed ID: 36265456
    [TBL] [Abstract][Full Text] [Related]  

  • 2. BET Bromodomain Inhibitors Which Permit Treg Function Enable a Combinatorial Strategy to Suppress GVHD in Pre-clinical Allogeneic HSCT.
    Copsel SN; Lightbourn CO; Barreras H; Lohse I; Wolf D; Bader CS; Manov J; Kale BJ; Shah D; Brothers SP; Perez VL; Komanduri KV; Wahlestedt C; Levy RB
    Front Immunol; 2018; 9():3104. PubMed ID: 30733722
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Highly Purified Alloantigen-Specific Tregs From Healthy and Chronic Kidney Disease Patients Can Be Long-Term Expanded, Maintaining a Suppressive Phenotype and Function in the Presence of Inflammatory Cytokines.
    Cortés-Hernández A; Alvarez-Salazar EK; Arteaga-Cruz S; Rosas-Cortina K; Linares N; Alberú Gómez JM; Soldevila G
    Front Immunol; 2021; 12():686530. PubMed ID: 34777330
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Amelioration of acute graft-versus-host disease by adoptive transfer of ex vivo expanded human cord blood CD4+CD25+ forkhead box protein 3+ regulatory T cells is associated with the polarization of Treg/Th17 balance in a mouse model.
    Yang J; Fan H; Hao J; Ren Y; Chen L; Li G; Xie R; Yang Y; Qian K; Liu M
    Transfusion; 2012 Jun; 52(6):1333-47. PubMed ID: 22098312
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Induction of granzyme B expression in T-cell receptor/CD28-stimulated human regulatory T cells is suppressed by inhibitors of the PI3K-mTOR pathway.
    Efimova OV; Kelley TW
    BMC Immunol; 2009 Nov; 10():59. PubMed ID: 19930596
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glucocorticoid hormone differentially modulates the in vitro expansion and cytokine profile of thymic and splenic Treg cells.
    Pap R; Ugor E; Litvai T; Prenek L; Najbauer J; Németh P; Berki T
    Immunobiology; 2019 Mar; 224(2):285-295. PubMed ID: 30612787
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparing the Effects of the mTOR Inhibitors Azithromycin and Rapamycin on In Vitro Expanded Regulatory T Cells.
    Bergström M; Müller M; Karlsson M; Scholz H; Vethe NT; Korsgren O
    Cell Transplant; 2019 Dec; 28(12):1603-1613. PubMed ID: 31512504
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical-grade regulatory T cells: Comparative analysis of large-scale expansion conditions.
    Velaga S; Alter C; Dringenberg U; Thiesler CT; Kuhs S; Olek S; Ukena SN; Franzke A
    Exp Hematol; 2017 Jan; 45():27-35.e1. PubMed ID: 27693388
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical-Grade-Expanded Regulatory T Cells Prevent Graft-versus-Host Disease While Allowing a Powerful T Cell-Dependent Graft-versus-Leukemia Effect in Murine Models.
    Del Papa B; Ruggeri L; Urbani E; Baldoni S; Cecchini D; Zei T; Iacucci Ostini R; Crescenzi B; Carotti A; Pierini A; Sportoletti P; Di Bartolomeo P; Falzetti F; Mecucci C; Velardi A; Martelli MF; Di Ianni M
    Biol Blood Marrow Transplant; 2017 Nov; 23(11):1847-1851. PubMed ID: 28729148
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Marked in Vivo Donor Regulatory T Cell Expansion via Interleukin-2 and TL1A-Ig Stimulation Ameliorates Graft-versus-Host Disease but Preserves Graft-versus-Leukemia in Recipients after Hematopoietic Stem Cell Transplantation.
    Wolf D; Barreras H; Bader CS; Copsel S; Lightbourn CO; Pfeiffer BJ; Altman NH; Podack ER; Komanduri KV; Levy RB
    Biol Blood Marrow Transplant; 2017 May; 23(5):757-766. PubMed ID: 28219835
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mobilized Multipotent Hematopoietic Progenitors Promote Expansion and Survival of Allogeneic Tregs and Protect Against Graft Versus Host Disease.
    D'Aveni M; Notarantonio AB; Agbogan VA; Bertrand A; Fouquet G; Gastineau P; Garfa-Traoré M; De Carvalho M; Hermine O; Rubio MT; Zavala F
    Front Immunol; 2020; 11():607180. PubMed ID: 33643294
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Generation of human regulatory T cells de novo with suppressive function prevent xenogeneic graft versus host disease.
    Qian X; Wang K; Wang X; Zheng SG; Lu L
    Int Immunopharmacol; 2011 May; 11(5):630-7. PubMed ID: 21147213
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of calcineurin abrogates while inhibition of mTOR promotes regulatory T cell expansion and graft-versus-host disease protection by IL-2 in allogeneic bone marrow transplantation.
    Satake A; Schmidt AM; Nomura S; Kambayashi T
    PLoS One; 2014; 9(3):e92888. PubMed ID: 24658577
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expansion of human regulatory T-cells from patients with type 1 diabetes.
    Putnam AL; Brusko TM; Lee MR; Liu W; Szot GL; Ghosh T; Atkinson MA; Bluestone JA
    Diabetes; 2009 Mar; 58(3):652-62. PubMed ID: 19074986
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of immunosuppressants on the therapeutic efficacy of in vitro-expanded CD4+CD25+Foxp3+ regulatory T cells in allotransplantation.
    Lim DG; Koo SK; Park YH; Kim Y; Kim HM; Park CS; Kim SC; Han DJ
    Transplantation; 2010 Apr; 89(8):928-36. PubMed ID: 20305583
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased Foxp3
    Chen YB; Efebera YA; Johnston L; Ball ED; Avigan D; Lekakis LJ; Bachier CR; Martin P; Duramad O; Ishii Y; Han S; Jung YJ; Lee D; Kunkel L; Negrin RS; Bui JD
    Biol Blood Marrow Transplant; 2017 Apr; 23(4):625-634. PubMed ID: 28104514
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rapamycin and IL-2 reduce lethal acute graft-versus-host disease associated with increased expansion of donor type CD4+CD25+Foxp3+ regulatory T cells.
    Shin HJ; Baker J; Leveson-Gower DB; Smith AT; Sega EI; Negrin RS
    Blood; 2011 Aug; 118(8):2342-50. PubMed ID: 21734238
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative analysis of dendritic cells and anti-CD3/CD28 expanded regulatory T cells for application in transplantation.
    Zeng M; Guinet E; Nouri-Shirazi M
    Transpl Immunol; 2009 Dec; 22(1-2):82-92. PubMed ID: 19635560
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ex-vivo expanded baboon CD4+ CD25 Hi Treg cells suppress baboon anti-pig T and B cell immune response.
    Singh AK; Seavey CN; Horvath KA; Mohiuddin MM
    Xenotransplantation; 2012; 19(2):102-11. PubMed ID: 22497512
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical-Grade Expanded Regulatory T Cells Are Enriched with Highly Suppressive Cells Producing IL-10, Granzyme B, and IL-35.
    Ulbar F; Villanova I; Giancola R; Baldoni S; Guardalupi F; Fabi B; Olioso P; Capone A; Sola R; Ciardelli S; Del Papa B; Brattelli A; Ricciardi I; Taricani S; Sabbatinelli G; Iuliani O; Passeri C; Sportoletti P; Santarone S; Pierini A; Calabrese G; Falzetti F; Bonfini T; Accorsi P; Ruggeri L; Martelli MF; Velardi A; Di Ianni M
    Biol Blood Marrow Transplant; 2020 Dec; 26(12):2204-2210. PubMed ID: 32961369
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.